Muraglitazar是一种PPAR α/γ的双激动剂，用于治疗2型糖尿病及相关血脂异常。Muraglitazar对人PPARα (EC50 = 320 nM)和PPARγ(EC50 = 110 nM)具有较强的体外活性。

Muraglitazar is a PPAR α/γ dual agonist for the treatment of type 2 diabetes and associated dyslipidemia. Muraglitazar shows potent activity in vitro at human PPARα and PPARγ with EC50 of 320 nM and 110 nM respectively.

331741-94-7

C29H28N2O7

516.54

BMS-298585;Pargluva

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years